Accepted 1 October 1976 pan blue was used to determine viability as in the method of Gorer and O'Gorman (1956) .
Cytotoxicity tests confirmed the QAKR and QC3H status of the AKR/Crc and AKR/Cum respectively.
The incidence of lymphomas was similar in both sublines, as shown in the Fig. It year. The AKR/Crc were comparable, in that 44/56 (78-6%) were dead with lymphoma within the same period.
It is noteworthy that reciprocal immunization between these virtually congenic sublines, where the only known difference is at the 0 locus, resulted in hightitre specific antisera.
Quite clearly the incidence of lymphoma in the AKR/Cum was comparable to that in the AKR/Crc. Similarly, the MuLV-gs titres are also comparable (Barnes and Brown, 1975) , although whether tumour incidence and viral load are strictly related is uncertain. This aside, these results indicate that there is no association between 0 status and lymphoma incidence. One positive useful factor emerging from the studies is that reciprocal immunizations between these 2 sublines provide a very convenient way of providing 2 corresponding anti-O sera, without the necessity of absorption prior to use.
